You just read:

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Patent in Australia for Its Novel Monotherapeutic Compounds to Treat CNS and PNS Disorders

News provided by

Medical Marijuana, Inc.

Mar 19, 2020, 09:00 ET